ClinicalTrials.gg
RecruitingNCT07564414Updated Sep 30, 2026

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

A Phase 3 interventional study of Cagrisema and Semaglutide in Obesity and Type 2 Diabetes, sponsored by Novo Nordisk A/S. Recruiting at 303 sites in 19 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Novo Nordisk A/S · Phase 3, Interventional, and Treatment

From the registry’s dates

  • Started May 2026; still recruiting 5 months later.
Updated Sep 30, 2026Site recruiting status changed2 sites added+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
2,500
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 36 studies testing cagrilintide in Obesity — 9 open to participants now, 15 under way, 9 of them phase 3. cagrilintide · Obesity.

Planned enrollment
2nd of 36
2,500 · median 154
Started
2026
with 9 others
Phase 3
15 of 36
4 open now
Primary completion
2028-02
later than 9 of 14 live
Registered
32nd of 36
by date
Lead sponsor
36 of 36
Novo Nordisk A/S

Among the 36 studies testing cagrilintide in Obesity, this one is the 2nd largest by planned enrollment, is one of 10 that started in 2026, is one of 15 in phase 3, reaches primary completion later than 9 of the 14 other live ones, and was the 32nd registered.

Obesity

11,543 studies on the registry are indexed under Obesity; 2,047 are open to participants now.

Browse Obesity studies →

Open to participants now

9 of the 36 studies testing cagrilintide in Obesity are open now, in 12 countries. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 9 open studies →

About cagrilintide

No approval found in the FDA or EMA files read. How studies give it is on its page →

Who these studies take

Of the 1,342 Obesity studies recruiting now, 377 (28%) set no upper age limit and 861 (64%) stop at 75 or younger; 168 take children under 18; 489 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 36 studies testing cagrilintide in Obesity, or all of them as a file.
02

Study summary

This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight. The purpose of the study is to find out how safe and effective CagriSema is for body weight loss in these participants. Participants will receive either CagriSema or semaglutide, and which treatment participants receive is decided by chance. CagriSema is a new study medicine being tested, while semaglutide is a medicine that doctors can already prescribe. The study will last for about 83 weeks

03

Conditions studied

  • Obesity
  • Type 2 Diabetes
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female (sex assigned at birth, inclusive of all gender identities).
  • Age 18 years or above at the time of signing the .
  • ≥ 35.0 kg/m\^2.
  • Participants without T2D: No history of T2D and \< 6.5% (48 millimoles per mole (mmol/mol)) Participants with T2D: A history of T2D and HbA1c \< 10% (\< 86 mmol/mol). If a participant without a history of diabetes during the screening period receives an HbA1c result of 6.5% (48 mmol/mol) or higher, the investigator or the participant's healthcare provider must confirm the diagnosis of type 2 diabetes before the participant is randomised.

Exclusion criteria

Exclusion Criteria:

  • A self-reported change in body weight > 5% within 90 days before screening, irrespective of medical records.
  • Use of any glucagon-like-peptide-1 receptor agonist (GLP-1 RA), including medication with GLP-1 RA activity, or amylin analogues, including medication with amylin activity, within 6 months before screening.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
2,500 participants (estimated)

Study arms

  • Experimental
    Cagrisema - dose level 1

    Participants will receive CagriSema at dose level 1 once weekly subcutaneously during the treatment period for 72 weeks.

    Drug: Cagrisema

  • Active comparator
    Cagrisema - dose level 2

    Participants will receive CagriSema at dose level 2 once weekly subcutaneously during the treatment period for 72 weeks.

    Drug: Cagrisema

  • Active comparator
    Semaglutide

    Participants will receive Semaglutide once weekly subcutaneously during the treatment period for 72 weeks.

    Drug: Semaglutide

Interventions

  • Cagrisema (Cagrilintide and Semaglutide) will be administered subcutaneously.

  • Semaglutide will be administered subcutaneously.

06

What researchers measure

Primary outcomes

  1. Relative change in body weight

    Measured as percentage (%).

    Time frame: From randomisation (week 0) to end of treatment (week 72)

Secondary outcomes

  1. Relative change in body weight

    Measured as %.

    Time frame: From randomisation (week 0) to end of treatment (week 72)

  2. Change in Body Mass Index (BMI)

    Measured as kilograms per square metre (kg/m\^2).

    Time frame: From randomisation (week 0) to end of treatment (week 72)

  3. Number of participants who achieve greater than or equal to (≥) 30% weight reduction

    Measured as count of participants.

    Time frame: From randomisation (week 0) to end of treatment (week 72)

  4. Number of participants who achieve ≥25% weight reduction

    Measured as count of participants.

    Time frame: From randomisation (week 0) to end of treatment (week 72)

  5. Number of participants who achieve greater ≥ 20% weight reduction

    Measured as count of participants.

    Time frame: From randomisation (week 0) to end of treatment (week 72)

  6. Change in waist circumference

    Measured in centimetre (cm).

    Time frame: From randomisation (week 0) to end of treatment (week 72)

  7. Mean change in body weight

    Measured in kilograms (kg).

    Time frame: From randomisation (week 0) to end of treatment (week 72)

  8. Number of participants who achieve a BMI less than (<) 30 kg/m^2

    Measured as count of participants.

    Time frame: From randomisation (week 0) to end of treatment (week 72)

  9. Number of participants who achieve BMI <27 kg/m^2

    Measured as count of participants.

    Time frame: end of treatment (week 72)

  10. Number of participants who achieve normal BMI, defined as 18.5 lesser than or equal to (≤) BMI < 25 kg/m^2

    Measured as count of participants.

    Time frame: At end of treatment (week 72)

  11. Number of participants who achieve a waist-to-height ratio < 0.53

    Measured as count of participants.

    Time frame: At end of treatment (week 72)

  12. Ratio to baseline : Total cholesterol

    Measured in terms of ratio.

    Time frame: From baseline (week 0) to end of treatment (week 72)

  13. Ratio to baseline : High density lipoprotein (HDL) cholesterol

    Measured in terms of ratio.

    Time frame: From baseline (week 0) to end of treatment (week 72)

  14. Ratio to baseline : Low density lipoprotein (LDL) cholesterol

    Measured in terms of ratio.

    Time frame: From baseline (week 0) to end of treatment (week 72)

  15. Ratio to baseline : Very low density lipoprotein ( VLDL) cholesterol

    Measured in terms of ratio.

    Time frame: From baseline (week 0) to end of treatment (week 72)

  16. Ratio to baseline : Triglycerides

    Measured in terms of ratio.

    Time frame: From baseline (week 0) to end of treatment (week 72)

  17. Ratio to baseline: Free fatty acids

    Measured in terms of ratio.

    Time frame: From baseline (week 0) to end of treatment (week 72)

  18. Ratio to baseline : Non-HDL cholesterol

    Measured in terms of ratio.

    Time frame: From baseline (week 0) to end of treatment (week 72)

  19. Change in Short-Form-36 Health Survey Version 2.0 (SF-36v2) physical Function

    Measured as score on a scale. The SF-36v2 acute measures health-related quality of life (HRQOL). The measure consists of 36 items yielding 8 health domain scores and 2 component summary scores. SF-36v2 acute scores are norm-based scores, i.e. transformed to a scale where the 2009 United States general population has a mean of 50 and a standard deviation of 10. Physical functioning score ranges from 19.0-57.6, with higher scores indicating better functional health and well-being.

    Time frame: From randomisation (week 0) to end of treatment (week 72)

  20. Change in Impact of Weight on Quality of Life-Lite Clinical Trials (IWQOL-Lite-CT) physical function

    Measured as score on a scale. IWQOL-Lite-CT measures weight-related physical and psychosocial functioning. The measure consists of 20 items yielding 3 composite scores, and 1 total score. Physical function score ranges from 0 to 100, with higher scores indicating better levels of functioning.

    Time frame: From randomisation (week 0) to end of treatment (week 72)

  21. Change in glycated haemoglobin (HbA1c)

    Measured in %-points.

    Time frame: From randomisation (week 0) to end of treatment (week 72)

  22. Number of participants who achieve HbA1c <6.5%

    Measured as count of participants.

    Time frame: At end of treatment (week 72)

  23. Number of participants who achieve normal HbA1c <5.7%

    Measured as count of participants.

    Time frame: At end of treatment (week 72)

  24. Number of treatment-emergent adverse events (TEAEs)

    Measured in number of events.

    Time frame: From randomisation (week 0) to end of study (week 80)

  25. Number of treatment-emergent serious adverse events (TESAEs)

    Measured in number of events.

    Time frame: From randomisation (week 0) to end of study (week 80)

07

Study locations

1 of 303 sites recruiting
  • Uni of Alabama at Birmingham
    Birmingham, Alabama 35294, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Cahaba Research
    Pelham, Alabama 35124, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Elligo Health Research Inc
    Gilbert, Arizona 85296, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Velocity Clinical Research-Phoenix
    Phoenix, Arizona 85006, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Arkansas Clinical Research
    Little Rock, Arkansas 72205, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Woodland Int. Research Group
    Little Rock, Arkansas 72211, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Headlands Research California, LLC
    Escondido, California 92025, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Neighborhood Healthcare
    Escondido, California 92025, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Diabetes & Endocrine Specialists - La Mesa
    La Mesa, California 91942, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Clinical Trials Research_Sacramento
    Lincoln, California 95648, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Loma Linda University Faculty Medical Clinics
    Loma Linda, California 92354, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Pacific Clinical Studies
    Los Alamitos, California 90720, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Valley Clinical Trials
    Northridge, California 91325, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Desert Oasis Healthcare
    Palm Springs, California 92262, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Linda Vista Health Care Ctr
    San Diego, California 92111, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Velocity Clin Res - Van Nuys
    Van Nuys, California 91405, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Flourish Research - CA
    Walnut Creek, California 94598, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • University of Colorado Hospital
    Aurora, Colorado 80045, United States
    Completed

    Not enrolling at this site — choose another above.

  • TBMR & Alcanza
    Clearwater, Florida 33761, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Northeast Research Institute
    Fleming Island, Florida 32003, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Northeast Research Institute
    Jacksonville, Florida 32204, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Westside Center For Clinical Research
    Jacksonville, Florida 32205, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Bioclinical Research Alliance
    Miami, Florida 33155, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • New Horizon Research Center
    Miami, Florida 33165, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • South Broward Research LLC
    Miramar, Florida 33027, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • West Orange Endocrinology
    Ocoee, Florida 34761, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Oviedo Medical Research, LLC
    Oviedo, Florida 32765, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Clinical Trial Services Corp
    Pembroke Pines, Florida 33024, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Hope Clin Res & Wellness
    Conyers, Georgia 30094, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Center for Adv Res & Education
    Gainesville, Georgia 30501, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Endocrine Research Solutions, Inc
    Roswell, Georgia 30076, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • North Georgia Clinical Research
    Woodstock, Georgia 30189-4255, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Solaris Clinical Research
    Meridian, Idaho 83646, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Cedar-Crosse Research Center
    Chicago, Illinois 60607, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Macoupin Fam Practice Ctr, LLP
    Gillespie, Illinois 62033, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Clinical Investigation Spec Gurnee
    Gurnee, Illinois 60031, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Endeavor Health
    Skokie, Illinois 60077, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Evanston Premier Hlthcr Res
    Skokie, Illinois 60077, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Iowa Diabetes Research
    West Des Moines, Iowa 50266, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Alliance for Multispecialty Research
    Newton, Kansas 67114, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Cotton O'Neil Diab & Endo Ctr
    Topeka, Kansas 66606, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • The Research Group of Lexington LLC
    Lexington, Kentucky 40503, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Endo and Metabolic Consultants
    Rockville, Maryland 20852, United States
    Not yet recruiting
  • Northern Pines Hlth Ctr, PC
    Buckley, Michigan 49620, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • International Diabetes Center
    Minneapolis, Minnesota 55416, United States
    Not yet recruiting
  • AES Minneapolis DRS
    Richfield, Minnesota 55423, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Belzoni Clinical Research
    Belzoni, Mississippi 39038, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Clinical Research Professionals
    Chesterfield, Missouri 63005, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Amicis Centers of Clinical Research
    St Louis, Missouri 63128, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Southgate Medical Group, LLP
    West Seneca, New York 14224, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • PharmQuest Life Sciences LLC
    Greensboro, North Carolina 27408, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Physician's East Endocrinology
    Greenville, North Carolina 27834, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Carteret Medical Group
    Morehead City, North Carolina 28557, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Centricity Rsrch MHCity Multi
    Morehead City, North Carolina 28557, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Piedmont Healthcare/Research
    Statesville, North Carolina 28625, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Accellacare Wilmington
    Wilmington, North Carolina 28401, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Lillestol Research LLC
    Fargo, North Dakota 58104, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Plains Clinical Research Center, LLC
    Fargo, North Dakota 58104, United States
    Not yet recruiting
  • Advanced Medical Research
    Maumee, Ohio 43537, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Alliance for Multispecialty Research
    Norman, Oklahoma 73069, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Lynn Institute of Norman
    Norman, Oklahoma 73072, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Heritage Valley Medical Group
    Beaver, Pennsylvania 15009, United States
    Not yet recruiting
  • Hatboro Med Associates
    Hatboro, Pennsylvania 19040, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Northeast Endocrine Metabolic Associates
    Philadelphia, Pennsylvania 19114, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Clinical Res Collaborative
    Cumberland, Rhode Island 02864, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Velocity Clinical Research-Gaffney
    Gaffney, South Carolina 29340, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Spartanburg Medical Research
    Spartanburg, South Carolina 29303, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Jackson Clinic
    Jackson, Tennessee 38305, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Holston Medical Group
    Kingsport, Tennessee 37660, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • CNS Healthcare
    Memphis, Tennessee 38119, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • HealthStar Physicians, PC
    Morristown, Tennessee 37813, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Clinical Research Associates
    Nashville, Tennessee 37203, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Amarillo Med Spec LLP
    Amarillo, Texas 79124, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Texas Diab & Endo, P.A.
    Austin, Texas 78731, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Velocity Clinical Research Austin
    Austin, Texas 78759, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Velocity Clin Res, Dallas
    Dallas, Texas 75230, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • North Texas Endocrine Center
    Dallas, Texas 75231, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Cedar Health Research
    Euless, Texas 76040, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • JCCT- Juno NW Houston
    Houston, Texas 77040, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • The Endocrine Center
    Houston, Texas 77079, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Medical Colleagues-Texas LLP
    Katy, Texas 77450, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Sante Clinical Research
    Kerrville, Texas 78028, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Radiance Clinical Research
    Lampasas, Texas 76550, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Aeres Clinical Research
    Laredo, Texas 78041, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • DCOL Ctr for Clin Res
    Longview, Texas 75605, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • RGV Endocrine Center
    McAllen, Texas 78503, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Quality Research Inc
    San Antonio, Texas 78209, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • AES San Antonio
    San Antonio, Texas 78229, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Northeast Clinical Research of San Antonio
    San Antonio, Texas 78233, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Consano Clinical Research, LLC
    Shavano Park, Texas 78231, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Mt Olympus Medical Research, LLC
    Sugar Land, Texas 77478, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • J.Lewis Research Inc
    Salt Lake City, Utah 84109, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • J.Lewis Research Inc
    Salt Lake City, Utah 84121, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Diabetes & Endo Tx Specialists
    Sandy City, Utah 84093, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • J.Lewis Research Inc
    South Jordan, Utah 84095, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Health Res of Hampton Roads
    Newport News, Virginia 23606, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Tidewater Physicians Multispecialty Group
    Newport News, Virginia 23606, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • National Clin Res Inc.
    Richmond, Virginia 23294, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Prevea Health
    Green Bay, Wisconsin 54303, United States
    Not yet recruiting
  • CEMEDIC
    CABA, Buenos Aires C1440CFD, Argentina
    Active, not recruiting

    Not enrolling at this site — choose another above.

Showing the first 100 of 303 sites across 19 countries. Choose a country and city above to see the rest.

08

References and documents

Individual participant data

Plan to share: Yes — According to the Novo Nordisk disclosure commitment on novonordisk-trials.com

Data sharing details ↗ · novonordisk-trials.com

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Feb 2028, 21 months after the start.

Of 199 industry-sponsored phase 3 interventional studies under Obesity, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 27. This study's planned 21 months is close to that.

Counting every sponsor, half of 262 studies reached it within 24 months; a quarter within 18 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 27, 2026
First posted
May 4, 2026
StartActual
May 21, 2026
Primary completionEst.
Feb 23, 2028
CompletionEst.
Apr 19, 2028
Last update
Sep 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
2 sites added, 2 sites removed. 160 sites changed recruiting status (154 now active, not recruiting, 6 now completed)
Show 160 sites
  • CEMEDIC · CABA, ArgentinaRecruiting→Active, not recruiting
  • Centro de Investigaciones Metabólicas · Capital Federal, ArgentinaRecruiting→Active, not recruiting
  • CICEMO- Consultorio (Av Directorio) · Ciudad Autónoma de Buenos Aires, ArgentinaRecruiting→Active, not recruiting
  • Centro Médico Arsema · Ciudad Autónoma de Buenos Aires, ArgentinaRecruiting→Active, not recruiting
  • Centro de Investigación C.I.C.E 9 de Julio - Sanatorio 9 de Julio · San Miguel de Tucumán, ArgentinaRecruiting→Active, not recruiting
  • OMI- Organización Médica de Investigación · Buenos Aires, ArgentinaRecruiting→Active, not recruiting
  • Kynet Recoleta · Buenos Aires, ArgentinaRecruiting→Active, not recruiting
  • Hospital Sirio Libanes · Buenos Aires, ArgentinaRecruiting→Active, not recruiting
  • Centro Medico Dra. Laura Maffei e Investigacion Clínica Apli · Buenos Aires, ArgentinaRecruiting→Active, not recruiting
  • CIPREC Arenales · CABA, ArgentinaRecruiting→Active, not recruiting
  • Centro Médico Viamonte SRL · CABA, ArgentinaRecruiting→Active, not recruiting
  • Instituto Centenario · Ciudad de Buenos Aires, ArgentinaRecruiting→Active, not recruiting
  • CEDIR - Centro de diagnóstico y rehabilitación Santa Fe · Santa Fe, ArgentinaRecruiting→Active, not recruiting
  • Sanatorio Norte · Santiago del Estero, ArgentinaRecruiting→Active, not recruiting
  • Sydney Clinical Trials · Campbelltown, AustraliaRecruiting→Active, not recruiting
  • Gosford Renal Research · Gosford, AustraliaRecruiting→Active, not recruiting
  • Sydney Cardiometabolic Centre · Liverpool, AustraliaRecruiting→Active, not recruiting
  • Hunter Diabetes Centre · Merewether, AustraliaRecruiting→Active, not recruiting
  • University of Sunshine Coast - Vitality Village · Birtinya, AustraliaRecruiting→Active, not recruiting
  • University of Sunshine Coast - South Brisbane · South Brisbane, AustraliaRecruiting→Active, not recruiting
  • Emeritus Research Melbourne · Camberwell, AustraliaRecruiting→Active, not recruiting
  • Medical University of Graz · Graz, AustriaRecruiting→Active, not recruiting
  • Ordination Winhofer-Stöckl · Mattersburg, AustriaRecruiting→Active, not recruiting
  • Fließer-Görzer [Ordination] · Saint Stefan, AustriaRecruiting→Active, not recruiting
  • Klinik Landstraße · Vienna, AustriaRecruiting→Active, not recruiting
  • Universitätsklinikum AKH Wien · Vienna, AustriaRecruiting→Active, not recruiting
  • Ordination Dr. Günter Sokol · Vienna, AustriaRecruiting→Active, not recruiting
  • Klinik Hietzing 3. Med. Abt. · Vienna, AustriaRecruiting→Active, not recruiting
  • Itariu [Ordination] · Vienna, AustriaRecruiting→Active, not recruiting
  • Anima Research Center · Alken, BelgiumRecruiting→Active, not recruiting
  • …and 130 more on the registry record
Show 2 added (1 Poland, 1 Portugal)
  • Gierach-Med · Bydgoszcz, Poland
  • Ucardio Centro Clinico Unidade Cardiovascular · Riachos, Torres Novas, Portugal
Show 2 removed
  • Gierach-Med · Bygdoszcz, Poland
  • Ucardio Centro Clinico Unidade Cardiovascular · Torres Novas, Portugal
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    2 sites added, 2 sites removed. 160 sites changed recruiting status (154 now active, not recruiting, 6 now completed)
    Show 160 sites
    • CEMEDIC · CABA, ArgentinaRecruiting→Active, not recruiting
    • Centro de Investigaciones Metabólicas · Capital Federal, ArgentinaRecruiting→Active, not recruiting
    • CICEMO- Consultorio (Av Directorio) · Ciudad Autónoma de Buenos Aires, ArgentinaRecruiting→Active, not recruiting
    • Centro Médico Arsema · Ciudad Autónoma de Buenos Aires, ArgentinaRecruiting→Active, not recruiting
    • Centro de Investigación C.I.C.E 9 de Julio - Sanatorio 9 de Julio · San Miguel de Tucumán, ArgentinaRecruiting→Active, not recruiting
    • OMI- Organización Médica de Investigación · Buenos Aires, ArgentinaRecruiting→Active, not recruiting
    • Kynet Recoleta · Buenos Aires, ArgentinaRecruiting→Active, not recruiting
    • Hospital Sirio Libanes · Buenos Aires, ArgentinaRecruiting→Active, not recruiting
    • Centro Medico Dra. Laura Maffei e Investigacion Clínica Apli · Buenos Aires, ArgentinaRecruiting→Active, not recruiting
    • CIPREC Arenales · CABA, ArgentinaRecruiting→Active, not recruiting
    • Centro Médico Viamonte SRL · CABA, ArgentinaRecruiting→Active, not recruiting
    • Instituto Centenario · Ciudad de Buenos Aires, ArgentinaRecruiting→Active, not recruiting
    • CEDIR - Centro de diagnóstico y rehabilitación Santa Fe · Santa Fe, ArgentinaRecruiting→Active, not recruiting
    • Sanatorio Norte · Santiago del Estero, ArgentinaRecruiting→Active, not recruiting
    • Sydney Clinical Trials · Campbelltown, AustraliaRecruiting→Active, not recruiting
    • Gosford Renal Research · Gosford, AustraliaRecruiting→Active, not recruiting
    • Sydney Cardiometabolic Centre · Liverpool, AustraliaRecruiting→Active, not recruiting
    • Hunter Diabetes Centre · Merewether, AustraliaRecruiting→Active, not recruiting
    • University of Sunshine Coast - Vitality Village · Birtinya, AustraliaRecruiting→Active, not recruiting
    • University of Sunshine Coast - South Brisbane · South Brisbane, AustraliaRecruiting→Active, not recruiting
    • Emeritus Research Melbourne · Camberwell, AustraliaRecruiting→Active, not recruiting
    • Medical University of Graz · Graz, AustriaRecruiting→Active, not recruiting
    • Ordination Winhofer-Stöckl · Mattersburg, AustriaRecruiting→Active, not recruiting
    • Fließer-Görzer [Ordination] · Saint Stefan, AustriaRecruiting→Active, not recruiting
    • Klinik Landstraße · Vienna, AustriaRecruiting→Active, not recruiting
    • Universitätsklinikum AKH Wien · Vienna, AustriaRecruiting→Active, not recruiting
    • Ordination Dr. Günter Sokol · Vienna, AustriaRecruiting→Active, not recruiting
    • Klinik Hietzing 3. Med. Abt. · Vienna, AustriaRecruiting→Active, not recruiting
    • Itariu [Ordination] · Vienna, AustriaRecruiting→Active, not recruiting
    • Anima Research Center · Alken, BelgiumRecruiting→Active, not recruiting
    • …and 130 more on the registry record
    Show 2 added (1 Poland, 1 Portugal)
    • Gierach-Med · Bydgoszcz, Poland
    • Ucardio Centro Clinico Unidade Cardiovascular · Riachos, Torres Novas, Portugal
    Show 2 removed
    • Gierach-Med · Bygdoszcz, Poland
    • Ucardio Centro Clinico Unidade Cardiovascular · Torres Novas, Portugal
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07564414
Lead sponsor
Novo Nordisk A/S
Responsible party
Sponsor
First posted
May 4, 2026
Start date
May 21, 2026
Primary completion
Feb 23, 2028 (estimated)
Completion
Apr 19, 2028 (estimated)
Last update
Sep 30, 2026

Study contacts

Novo Nordisk
Contact
clinicaltrials@novonordisk.com
(+1) 866-867-7178
Clinical Transparency (dept. 2834)
study director · Novo Nordisk A/S

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Cagrilintide

Start the discussion